Clinical Trial Update: Valproic Acid in Treating Patients With Progressive, Non-Metastatic Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating valproic acid in progressive, non-metastatic prostate cancer was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• VALPROIC ACID (Valproic acid)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Prostate Cancer | Phase 2 | Status: TERMINATED | Results posted: 2018-09-28